title: It's about change...regenerative medicine in the Obama era.
abstract: During his campaign, US President-elect Obama pledged to use an executive order to overturn federal-funding limits on research into human embryos that are created during fertility treatments imposed by President Bush. Robert Klein, Chairman of the Governing Board of California's stem cell funding agency, Governor Jim Doyle, and Bernard Siegel, Executive Director of the Genetics Policy Institute, discuss the implications of the new administration for regenerative medicine research in the USA.
authors.affiliation: California Institute for Regenerative Medicine, Governing Board of CIRM, Independent Citizens' Oversight Committee, 210 King Street, San Francisco, CA 94107, USA.
authors.forename: Robert N
authors.initials: RN
authors.lastname: Klein
authors.forename: Jim
authors.initials: J
authors.lastname: Doyle
authors.forename: Bernard
authors.initials: B
authors.lastname: Siegel
mesh_terms: D033041:Embryo Research / Q000191:economics* / Q000331:legislation & jurisprudence; D035082:Federal Government; D005380:Financing, Government; D033161:Government Regulation; D006801:Humans; D044968:Regenerative Medicine / Q000191:economics* / Q000331:legislation & jurisprudence; D014481:United States